Cargando…

MiR-659-3p inhibits osteosarcoma progression and metastasis by inhibiting cell proliferation and invasion via targeting SRPK1

OBJECTIVE: Osteosarcoma is the most common primary bone cancer that affects mostly children and young adults. Despite the advances in osteosarcoma treatment, the long-term survival rate of metastatic patients has not significantly improved in the past few decades, thus demonstrating the need for nov...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Yubao, Wei, Zheng-Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425973/
https://www.ncbi.nlm.nih.gov/pubmed/36038837
http://dx.doi.org/10.1186/s12885-022-10029-0